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Introduction
Stereoelectronic substituent effects have a profound effect on
the three-dimensional structures of molecules. Whereas sub-
stituents on a cyclic compound generally have a preference for
(pseudo)equatorial positions for steric reasons, the electronic
spatial preferences depend on different forces such as charge–
charge and dipole–dipole interactions.[1] The conformation and
reactivity of carbohydrates are determined to a large extent by
the natures and orientations of the substituents. This influence
becomes apparent in glycosylation reactions, in which the
amount, nature and orientation of the hydroxy groups, pro-
tected with electron-withdrawing esters or more electron-neu-
tral ether groups, determine the overall reactivity.[2]
It has long been known that, in glycosylations, axial substitu-
ents are less deactivating or “disarming” than their equatorially
positioned equivalents.[3] Similarly, the basicity of iminosugars
(or “azasugars”), carbohydrates in which the endocyclic oxygen
atom is replaced by an amine group, is influenced by the ori-
entation of the ring substituents, with azasugars bearing more
axially positioned hydroxy groups being more basic than their
stereoisomers bearing equatorially positioned substituents.[4]
These effects can be explained in terms of more favourable
interaction of the axially positioned electronegative oxygen
substituents with the positive charge present on the azasugar
ring in a protonated state and the (partial) positive charge of
oxocarbenium ion (-like) intermediates in glycosylation reac-
tions.[4–7]
In mannuronic acids, mannosides in which the C6-OH group
is oxidised to a carboxylic acid functionality, the carboxylic acid
has a profound effect on the conformation and reactivity of
the pyranoside.[8] In the context of the construction of bacterial
oligosaccharides we have studied the glycosylation behaviour
of a variety of mannuronic acid donors in detail and we have
found these to be unexpectedly reactive.[9] In addition, glycosy-
lations involving these donors proceed with an extraordinary
selectivity to provide 1,2-cis glycosidic linkages. These findings
were explained in terms of the conformational preferences of
(partially) positively charged mannuronic acid oxocarbenium
ion (-like) intermediates that are governed by the ring substitu-
ent effects. These species prefer to adopt a “flipped” ring struc-
ture and in the 3H4 (-like) oxocarbenium ion all substituents
take up the most stabilising (or least destabilising) orientation:
the C2-OR pseudoequatorial and the C3-, C4-OR and C5-COOR
groups pseudoaxial. Indeed, DFT calculations indicate that the
3H4 oxocarbenium ion is significantly more stable than the al-
ternative (“non-ring-flipped”) 4H3 ion (Scheme 1A).
[10]
A set of mannuronic-acid-based iminosugars, consisting of the
C-5-carboxylic acid, methyl ester and amide analogues of 1-
deoxymannorjirimicin (DMJ), was synthesised and their pH-de-
pendent conformational behaviour was studied. Under acidic
conditions the methyl ester and the carboxylic acid adopted
an “inverted” 1C4 chair conformation as opposed to the
“normal” 4C1 chair at basic pH. This conformational change is
explained in terms of the stereoelectronic effects of the ring
substituents and it parallels the behaviour of the mannuronic
acid ester oxocarbenium ion. Because of this solution-phase
behaviour, the mannuronic acid ester azasugar was examined
as an inhibitor for a Caulobacter GH47 mannosidase that hy-
drolyses its substrates by way of a reaction itinerary that pro-
ceeds through a 3H4 transition state. No binding was observed
for the mannuronic acid ester azasugar, but sub-atomic resolu-
tion data were obtained for the DMJ·CkGH47 complex, show-
ing two conformations—3S1 and
1C4—for the DMJ inhibitor.
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Carbohydrate-processing enzymes, such as glycoside hydro-
lases, may induce a chemical transformation by forcing the car-
bohydrate substrate into an unusual conformation.[11] a-Man-
nosidases that belong to the CAZY family GH47 are inverting
glycoside hydrolases that cleave a-1,2-mannosidic linkages.
The mammalian GH47 mannosidases can be found in the
Golgi and endoplasmatic reticulum (ER), where they cleave
mannose residues from N-glycans, thereby playing an impor-
tant role in protein biosynthesis and quality control. The mech-
anism by which these hydrolases cleave the 1,2-mannosidic
bonds is notable because they employ an unusual catalytic
itinerary. The substrate that is to be cleaved binds in a 3,OB/3S1
conformation and is hydrolysed in a reaction that proceeds
through a transition state in which the mannose ring adopts
a 3H4 conformation.
[12] Kifunesine (1, Scheme 1B), a potent
inhibitor of the mannosidase I enzyme, has been shown to
adopt a ring-flipped 1C4 conformation, and a similar conforma-
tion was found for 1-deoxymannojirimycin (DMJ, 2,
Scheme 1B) bound in the active site of Saccharomyces cerevi-
siae.[12]
We were inspired by the conformations of the inhibitors of
the GH47 enzymes to explore the behaviour of azasugars
based on mannuronic acid. Here we report on the synthesis of
mannuronic-acid-based azasugars 3, 4 and 5 (Scheme 1C) and
their conformational behaviour. We show that the stereoelec-
tronic effects that determine the structures of the mannuronic
acid oxocarbenium ions also impact the three-dimensional
structures of these azasugars and that protonation of the ring
nitrogen can induce a ring flip leading to an axial-rich 1C4 con-
formation in solution. We build on this to show how deoxy-
mannojirimycin, the “parent” compound, binds to a bacterial
GH47 enzyme from Caulobacter sp. K31[12] but also that—un-
fortunately, despite improved solution behaviour—the man-
nuronic acid derivatives do not bind to the GH47 enzyme,
likely by virtue of their altered C5-substituents.
Results and Discussion
The synthesis of DMJ (2) and its C5 analogues was achieved
according to the route devised by Wrodnigg and co-workers.[13]
As depicted in Scheme 2, methyl mannuronic acid ester azasu-
gar 3 was obtained in four steps from the commercially avail-
able calcium d-gluconate monohydrate (6).[14] The gluconate 6
was treated with HBr in acetic acid to form 3,5-di-O-acetyl-2,6-
dibromo-2,6-dideoxy-d-manno-1,4-lactone after a series of
acid-catalysed transformations (i.e. , substitution of the C2 and
C6 hydroxy groups, intramolecular ring closure and acetylation
of the remaining hydroxy groups). Next, the acetyl groups at
O3 and O5 were removed in an acid-catalysed transesterifica-
tion with methanol to provide the pure dibromolactone 7
after crystallisation from chloroform/water, in 26% yield over
the two steps. Regioselective displacement of the C2 bromide
with an azide occurred with retention of configuration, as ex-
plained by Bock et al.[15] with epimerisation of the C2-bromide
to the more reactive glucose-configured dibromide and subse-
quent regioselective substitution by the azide. Thereafter, pal-
ladium-catalysed reduction of the intermediate azide and sub-
sequent crystallisation from ethanol gave 2-amino-6-bromolac-
tone 8 as its hydrochloric acid salt in 55% yield. Treatment of
this salt with triethylamine in methanol led to ring opening
and intramolecular bromide displacement by the C2 amine to
give crude azasugar methyl ester 3.
Purification of this compound from the triethylammonium
and sodium salts formed in the reaction proved difficult, be-
cause of the high polarity of the compound as well as the la-
bility of the methyl ester towards hydrolysis. Attempts to crys-
tallise the compound were to no avail. Therefore, all of the hy-
droxy groups in 3 were capped with trimethylsilyl groups[16] to
allow for the purification of the compound by chromatogra-
Scheme 1. A) Conformational equilibrium for the mannuronic acid oxocarbe-
nium ion. B) Structures of the mannosidase inhibitors kifunensine (1) and 1-
deoxymannojirimycin (DMJ, 2) in the 1C4 conformation. C) Mannuronic acid
azasugars studied here.
Scheme 2. Synthesis of DMJ and its C5 analogues for this study. Reaction
conditions: a) i : HBr, AcOH; ii : MeOH, 26% over two steps; b) i : NaN3, ace-
tone; ii : H2, Pd/C, HCl (aq.), MeOH, 55% over two steps; c) i : Et3N, MeOH,
quant. ; ii : HMDS, CuSO4·H2O (cat.), CAN; iii : MeOH, AcCl (cat), 70% over
three steps. d) NaBH4, EtOH, 29%; e) NaOH, H2O, quant. ; f) NH3, MeOH,
quant.
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phy. After desilylation, the pure methyl ester 3 was obtained
as its hydrochloric acid salt.
DMJ (2) was synthesised from 3 by a sodium-borohydride-
mediated reduction and was obtained in 29% yield after
column chromatography. d-Mannuronic acid azasugar 4 and
amide 5 were obtained from 3 through saponification with
sodium hydroxide or aminolysis with methanolic ammonia, re-
spectively.
With the set of azasugars to hand we established their pKa
values by titration and investigated their conformational be-
haviour at different pH* (the pH measured in D2O) values by
NMR spectroscopy. Table 1 summarises the results of these
studies. For DMJ a pKa value of 7.4 was measured, in line with
the pKa previously established for this compound (7.5).
[4c] The
pKa values of methyl ester 3, amino acid 4 and amide 5 were
determined to be 5.3, 7.5 and 5.8, respectively. The drop in pKa
value for the ester and the amide is a clear manifestation of
the electron-withdrawing effect of the carboxylic acid ester
and amide functionalities. At higher pH*, at which acid 4 is de-
protonated, the electron-withdrawing effect of the carboxylate
is lowered because of its negative charge.
Figures 1–4 show the 1H NMR spectra of azasugars 2–5
recorded at varying pH* values. In Figure 1, 1H NMR spectra of
DMJ (2) in D2O at pH* 1–12 are collected. From pH* 1 to
pH* 6.5 no changes are observed either in chemical shifts or in
coupling constants. The coupling constants are indicative of
a “normal” 4C1 chair conformation for the azasugar ring. On
going from pH* 6.5 to pH* 12 significant shifts in chemical
shift are observed for all ring protons, with the direct neigh-
bours of the amino group experiencing the largest shifts. No
changes in the coupling constants of the ring protons are ob-
served, thus indicating that no major conformation change
takes place.
In Figure 2, the 1H NMR spectra of methyl ester 3 at different
pH* values are displayed. Because hydrolysis of the methyl
ester was observed above pH* 8, no spectra were recorded
above this pH*. Large chemical shift changes are seen with
increasing pH*. Especially, H5 shows a large chemical shift
change and shifts from d=4.04 at pH* 2 to 3.22 at pH* 8. In
addition, a change in coupling constants is observed for the
ring protons. For example, J3,4 changes from 9.4 Hz at basic
pH* to 7.5 Hz at acidic pH*, indicative of a change in confor-
mation of the azasugar ring. At high pH* the azasugar adopts
a single conformation, whereas both the 1C4 and
4C1 conform-
ers are present at low pH* (vide infra).
Mannuronic acid 4 can exist in three different charged
states: the fully protonated state, the neutral zwitterionic state
and the negatively charged state. Figure 3 shows 1H NMR spec-
tra of 4 from pH* 1 to pH* 12. Again, large chemical shift
changes are observed with changing pH* (especially for H5,
which shows a shift from d=3.9 to d=2.9 ppm). A small
change in coupling constants is also apparent: J3,4 changes
from 9.8 Hz at high pH* to 8.8 Hz at neutral pH* to 8.3 Hz at
acidic pH*. Thus, in line with the conformational behaviour of
methyl ester 3, mannonic acid 4 can change its conformation
in a pH-dependent manner.
Figure 4 displays a set of 1H NMR spectra for amide 5 at dif-
ferent pH* values. Smaller changes are observed for the chemi-
Figure 1. 400 MHz 1H NMR spectra for DMJ (2) at different pH* values; spectra are referenced to residual methanol.
Table 1. pKa values for compounds 2–5 and observed and calculated
coupling constants and determined 4C1:
1C4 conformer ratio.
Compound pH* J3-4 (obs.) J3-4 (calcd) NMR ratio pKa
4C1
1C4
4C1:
1C4
2 9 9.5 9.0 3.3 100:0 7.4
2 9.5 9.4 4.3 100:0
3 8 9.4 9.4 3.9 99:1 5.3
2 7.5 9.5 4.9 56:44
4 11 9.8 9.3 3.1 100:0 7.5
5 8.8 9.1 3.8 94:6
1 8.3 9.5 4.7 75:25
5 9 9.7 9.0 2.8 100:0 5.8
2 9.3 9.1 4.7 100:0
3 CD3OD 9.2 9.3 4.2 99:1
CD3OD (+TFA) 4.8 9.3 4.7 1:99
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cal shift change of H5 and there is no significant change in the
coupling constants, thus indicating minimal conformation
changes on going from high to low pH* for this azasugar.
To establish the ratio of 1C4 and
4C1 conformers for the differ-
ent azasugars we used DFT calculations to determine the cou-
pling constants of the two conformers of both the protonated
and the deprotonated azasugars (for details see the Support-
ing Information).[17] Table 1 shows the measured coupling con-
stants (J3,4) for the four azasugars at low and high pH* values,
the calculated J3,4 values for the
4C1 and
1C4 conformers and
the ratios of the two conformers, established from the mea-
sured average coupling constants. As can be seen from
Figure 2. 1H NMR spectra for 2,6-dideoxy-2,6-iminomannuronic acid methyl ester (3) at different pH* values; spectra are referenced to residual methanol.
Figure 3. 1H NMR spectra for 2,6-dideoxy-2,6-iminomannonic acid (4) at different pH* values; spectra are referenced to water.
Figure 4. 1H NMR spectra for 2,6-dideoxy-2,6-iminomannuronic amide (5) at different pH* values; spectra are referenced to water.
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Table 1, there is good agreement between the calculated and
the measured coupling constants at high pH* values. With the
two values for J3,4 the ratios of the
1C4 and
4C1 conformers were
established. It is clear that DMJ (2) exists in a single 4C1 confor-
mation at both low and high pH values. For the methyl ester 3
the situation is different. With the calculated values for the
coupling constants of both conformers (J3,4=9.5 Hz and 4.9 Hz
for the 1C4 and
4C1 azasugars, respectively) and the measured
average coupling constant (J3,4=7.5 Hz) the ratio of the two
conformers was established to be 56:44, thus indicating that
the two chair conformers are equally stable. In similar vein, the
ratio of the two chair conformers of the acid 4 was determined
at three different pH values. As can be seen in Table 1, at high
pH the anionic azasugar 4 exists as a single conformer, where-
as at pH 5 the measured average coupling constant indicates
a 94:6 mixture of conformers. At low pH the two conformers
are observed in a 75:25 4C1/
1C4 ratio. For the amide 5, at both
high and low pH the 4C1 chair is almost exclusively present.
To investigate the conformational behaviour in a less polar
environment, the azasugar showing the largest conformational
change, methyl ester 3, was investigated in CD3OD. Figure 5
shows the spectra of the non-protonated and the protonated
azasugar. In this medium the J3,4 coupling constant changes
from 9.2 Hz to 4.8 Hz upon protonation, thus indicating that
the non-protonated azasugar exists in the 4C1 conformation
whereas the protonated species is found in the opposite 1C4
conformation.
The NMR results show that DMJ analogues possessing a
methyl ester or carboxylic acid at C5 (as in 3 and 4, respective-
ly) can change their conformation from the 4C1 chair form to
the opposite 1C4 chair upon protonation. This conformational
change is seen even in a highly polar medium such as water
and is significantly enhanced in a more apolar solvent
(CD3OD). The nature of the substituent at C5 of the DMJ ana-
logues is of major importance, because DMJ (2) and its C5
amide 5 do not display any conformational change with
changing pH. The difference between the ester and amide is
notable, because both functional groups—the C5 carboxylic
acid ester and the C5 carboxamide—have a similar effect on
the basicity of the azasugars. The electron-withdrawing effect
of both groups leads to a significant drop in the pKa values for
3 and 5, with the more strongly electron-withdrawing func-
tionality—the ester—having the stronger inductive effect. The
conformational flip of ester 3 and acid 4 can be accounted for
by considering that electron-withdrawing groups prefer to
occupy an axial position on a positively charged pyranose ring
to minimise their destabilising effect.[4–7] The fact that amide 5
does not change its conformation to accommodate this intrin-
sic preference might be due to internal hydrogen bonds that
can be formed between the amide -NH2 and the C4-OH, which
provides an extra stabilising factor in the 4C1 amide.
[18]
Having established that the mannuronic acid azasugars
readily undergo ring flip upon protonation we probed the
binding of the azasugars in the binding pocket of the a-1,2-
mannosidase GH47, from the Caulobacter K31 strain. All four
compounds were tested for binding through X-ray crystallogra-
phy and isothermal titration calorimetry. Initially we analysed
the binding of the parent compound DMJ (2).
DMJ (2) binds to CkGH47 with a KD of 481 nm (determined
by isothermal titration calorimetry, Figure 6A). Although DMJ
binding is essentially as observed previously for the mammali-
an GH47 structures,[19] the subatomic resolution data (Support-
ing Information) in this case allow us to observe DMJ bound in
the active site of CkGH47 in two different ring conformations
(Figure 6B). In the @1 subsite, the conformation of DMJ is in
both 3S1 and
1C4, each with a modelled occupancy of 0.5. Both
conformations are consistent with the conformational itinerary
of GH47 in which the structure adopts a 3S1 conformation in
the Michaelis complex to react via a 3H4 transition state to
form the product in a 1C4 conformation.
[12,19, 20] This dual-confor-
mation observation could perhaps be explained by the proxim-
ity of the pH of the crystallisation conditions (6.5) to the pKa of
DMJ (7.5) and the protonation of the species, although one
cannot deconvolute which conformer relates to which proto-
nation state).
The structure (PDB ID: 5MEH) confirms proposals made by
others, and by us, concerning the catalytic apparatus.[12,19, 20]
Briefly, catalytic base E365 is hydrogen-bonded to the O6 of
Figure 5. DMJ methyl ester (3) in CD3OD (&0.7 mL). The non-protonated azasugar is shown on top (no TFA added), the protonated azasugar on the bottom
(25 mL TFA added). Spectra are referenced to CD2HOD.
ChemBioChem 2017, 18, 1297 – 1304 www.chembiochem.org T 2017 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim1301
Full Papers
DMJ, at 2.6 a. It is held in place by the nucleophilic water,
which in turn is coordinated by calcium. The indirect route to
protonic assistance is likely given by the Oe2 of E121, although
a role for D249 has also been considered. The riding hydro-
gens of this bond are visible, matching the level of detail of
structure achieved by Thompson et al.[12a] With the assistance
of a metal ion, the O2-C2-C3-O3 torsion angle of a 4C1 confor-
mation is tightened from &608 to 0–158, consistent with the
known conformational pathway of GH47 via a 3H4 transition
state.[12,19, 20]
Unfortunately, despite promising solution characteristics
(Table 1), we were not able to detect binding of mannuronic
acid derivatives 3, 4 or 5. Simple modelling of these com-
pounds in the active centre, using the DMJ complex as a tem-
plate, suggested that the likely reason would be steric clashes
with residues in the active site, in particular E427. To test this
hypothesis, a mutant containing an E427A mutation to in-
crease the size of the active site was produced; however, at-
tempts to obtain complexes with this variant still did not allow
observation of 3–5 in the @1 subsite of the enzyme (data not
shown), thus suggesting that further steric clashes might also
be contributing to the lack of inhibition.
Conclusion
Azasugars based on mannuronic acid can change their confor-
mation from a “normal” 4C1 chair to the inverted
1C4 chair form
upon protonation of the endocyclic amine. The molecules
thereby position their substituents such that they are optimally
positioned to accommodate the positive charge. Although the
conformational behaviour of other glycuronic-acid-based aza-
sugars with different substituent configurations has not yet
been studied in detail, it is likely that the spatial preferences of
the substituents in the mannuronic acid azasugar work in con-
cert to affect the ring flip. This behaviour is in line with the
conformational effects observed for fully protected mannuron-
ic acid glycosyl donors, and therefore the results described
here provide an extra indication that the positive charge at the
anomeric centre of a mannuronic acid oxocarbenium ion is
responsible for the observed unusual ring flip. This intriguing
ring-flipping behaviour pointed to the potential use of the
mannuronic acid azasugars as inhibitors for mannosidases that
hydrolyse their substrates through a ring-flipped conformation-
al itinerary. Unfortunately, the mannuronic acid azasugars did
not bind to the studied GH47 mannosidase. Although the con-
cept of chemically flipped inhibitors worked in solution, espe-
cially in low-polarity buffers, they sadly highlight the challeng-
es of conformationally specific enzyme inhibition. For, whilst
the introduction of favourable chemistry—including, in some
cases, locking groups—frequently introduces substituents that
prevent binding for steric reasons, in enzyme active centres
that have evolved to harness the interactions of and thus dis-
tort unsubstituted sugars (e.g. , the elegant locking of a manno-
side mimic into B2,5 conformation with a three-carbon
bridge[21]—in order to target B2,5 transition-state mannosidases
specifically) it simply resulted in steric clashes with the target
b-mannosidase and no inhibition of the wild-type enzyme.[22]
Indeed, although the concept of conformation-specific target-
ed inhibition is one of the most exciting in glycochemistry, it is
only rarely achieved: the use of ring-flipped kifunensine (1) to
inhibit “southern hemisphere” mannosidases is one of the very
few cases in which a conformationally restrained inhibitor
works (and has indeed found considerable application in cell
biology).[23] The challenge therefore is still to provide the spe-
cific tools and therapeutic compounds required for cellular or
patient use, whilst also maintaining binding to the target
enzyme.
Experimental Section
General methods for organic synthesis : All reagents were of com-
mercial grade and used as received unless stated otherwise. Reac-
tions were performed at room temperature unless stated other-
wise. Molecular sieves (4 a) were flame-dried before use. Flash
column chromatography was performed on silica gel (40–63 mm).
1H and 13C NMR spectra were recorded with Bruker AV 600, Bruker
AV 400 or Bruker DPX 400 spectrometers in D2O or CD3OD. Chemi-
cal shifts (d) are given in ppm relative to the solvent residual sig-
nals. Coupling constants (J) are given in Hz. All given 13C spectra
are proton-decoupled. Compound names are given with use of the
standard iminosugar nomenclature numbering.
2,6-Dibromo-2,6-dideoxy-d-mannono-1,4-lactone (7): Calcium d-
gluconate monohydrate (6, 126 g, 280 mmol) was put under argon
before being dissolved in 33% HBr in acetic acid (500 mL, 3.0 mol).
The reaction mixture was stirred for 18 h to give an acetylated
form of 6. MeOH (1 L) was added, and the mixture was heated at
reflux for 2 h. It was then concentrated to half its original volume
under reduced pressure before addition of more MeOH (500 mL).
The reaction mixture was left to stir overnight, after which it was
concentrated, resulting in a slightly oily residue. This was co-evapo-
rated with MeOH (100 mL) and three times with H2O (100 mL). The
residue was extracted with diethyl ether (4V100 mL), and the or-
ganic layers were combined, dried with MgSO4, filtered and con-
centrated under vacuum, yielding a yellow oily residue. This was
Figure 6. Binding of DMJ (2) to CkGH47. A) ITC-derived thermodynamics of
binding. The stoichiometry (n) was 0.96:0.01 sites. The association constant
(KA) was (2.1V10
6:3.3V105)m@1. The enthalpy change (DH) was
(1140:150) calmol@1. B) Divergent wall-eyed stereo electron density for the
structure of CkGH47 in complex with DMJ (2, with the two conformations
shown with grey/purple bonds). The map shown is a maximum-likelihood/
sA weighted 2Fobs@Fcalcd, contoured at 0.87 electronsa@3. The active centre
calcium is shown as a green sphere and a water (Wat)—likely equating to
the nucleophilic water in catalysis—is shown as a red sphere. Key active
centre residues discussed in the text are labelled.
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crystallised from CHCl3/H2O to yield a white crystalline solid (44 g,
146 mmol, 26% yield). M.p. 130 8C; [a]20D =+58.68 (c=1, MeOH);
1H NMR (400 MHz, D2O): d=5.20 (d, J=4.5 Hz, 1H; C-2), 4.64 (m,
2H; C-4, C-3), 4.19 (m, 1H; C-5), 3.77 (dd, J=11.4, 2,4 Hz, 1H; C-6a),
3.65 ppm (dd, J=11.4, 4.9 Hz, 1H; C-6b); 13C NMR (101 MHz, D2O):
d=174.0 (C-1), 81.6 (C-4), 69.1 (C-3), 66.2 (C-5), 47.6 (C-2), 36.6 ppm
(C-6).
2-Amino-6-bromo-2,6-dideoxy-d-mannono-1,4-lactone hydro-
chloride (8): 2,6-Dibromo-2,6-dideoxy-d-mannono-1,4-lactone (7,
5.0 g, 16.5 mmol) was put under argon and dissolved in dry ace-
tone (MgSO4, 100 mL). Sodium azide Caution: highly toxic (15.0 g,
231 mmol) was added, and the suspension was heated at reflux for
20 h. The mixture was filtered, and the filtrate was concentrated
under reduced pressure. The residue was dissolved in H2O (50 mL)
and extracted with diethyl ether (5V100 mL), and the organic
layers were combined, dried over MgSO4, filtered and concentrated
under reduced pressure to give a brown oil that was identified as
the 2-azido compound but included some of its diastereoisomer.
1H NMR (400 MHz, D2O): d=4.68 (dd, J=4.5, 3.3 Hz, 1H; C-3), 4.56
(d, J=4.6 Hz, 1H; C-2), 4.46 (dd, J=9.2, 2.7 Hz, 1H; C-4), 4.09 (m,
1H; C-5), 3.69 (dd, J=11.4, 2.7 Hz, 1H; C-6a), 3.56 ppm (dd, J=
11.5, 4.9 Hz, 1H; C-6b); 13C NMR (101 MHz, D2O): d=174.1 (C-1),
81.0 (C-4), 69.6, 65.7 (C-3, C-5), 62.3 (C-2), 36.6 ppm (C-6).
The crude compound (16.5 mmol) was put under argon and dis-
solved in MeOH (100 mL). Palladium on activated carbon (10%,
300 mg, 0.3 mmol) and HCl (37% in H2O, 10 mL, 121 mmol) were
added, and the suspension was put under hydrogen. The reaction
mixture was stirred for 22 h, after which the catalyst was filtered
off over a Whatman microfilter. The filtrate was concentrated
under reduced pressure and co-evaporated once with HCl (37% in
H2O, 60 mL), thrice with toluene (60 mL) and once with CHCl3
(50 mL). Crystallisation from EtOH yielded 2-amino-6-bromo-2,6-di-
deoxy-d-mannono-1,4-lactone hydrochloride (8) as white crystals
(2.6 g, 9.2 mmol, 55% over two steps). M.p. 207 8C (decomp.) ;
[a]20D =+41.68 (c=1, MeOH);
1H NMR (400 MHz, D2O): d=4.83 (dd,
J=4.8, 2.8 Hz, 1H; C-3), 4.63 (dd, J=9.2, 2.7 Hz, 1H; C-4), 4.59 (d,
J=4.9 Hz, 1H; C-2), 4.20 (m, 1H; C-5), 3.77 (dd, J=11.5, 2.6 Hz, 1H;
C-6a), 3.65 ppm (dd, J=11.4, 5.0 Hz, 1H; C-6b); 13C NMR (101 MHz,
D2O): d=172.1 (C-1), 78.9 (C-4), 64.1 (C-3), 62.9 (C-5), 50.2 (C-2),
33.7 ppm (C-6).
1-Deoxymannojirimycin (2): 2-Amino-6-bromo-2,6-dideoxy-d-man-
nono-1,4-lactone hydrochloride (8, 501 mg, 1.8 mmol) was co-
evaporated three times with dry toluene, put under argon and sus-
pended in dry MeOH (10 mL). The suspension was cooled to 0 8C
before addition of distilled triethylamine (1.0 mL, 7.2 mmol), and
the resulting clear solution was stirred overnight. The reaction mix-
ture was concentrated under reduced pressure, yielding the
methyl ester as a white semicrystalline solid. The residue was put
under argon, dissolved in dry EtOH (molsieves, 10 mL) and cooled
to 0 8C. Sodium borohydride (709 mg, 19 mmol) was added, and
the suspension was stirred overnight. Dry MeOH (20 mL) was
added, after which the mixture was filtered, concentrated under
reduced pressure and co-evaporated with HCl in MeOH (1m, 3V
10 mL). The residue was purified by column chromatography
(EtOAc/EtOH 1:1!100% EtOH), yielding a pure sample of DMJ (2)
in 29% yield (105 mg, 0.50 mmol). [a]20D =@14.08 (c=0.5, MeOH);[13]
1H NMR (399 MHz, D2O): d=3.99 (dt, J=2.9, 1.6 Hz, 1H; C-3), 3.76
(dd, J=12.5, 3.9 Hz, 1H; C-7), 3.71 (dd, J=12.5, 5.5 Hz, 1H; C-7a),
3.60 (t, J=9.7 Hz, 1H; C-5), 3.53 (dd, J=9.6, 3.1 Hz, 1H; C-4), 3.03
(dd, J=14.2, 2.8 Hz, 1H; C-2a), 2.80 (dd, J=14.2, 1.5 Hz, 1H; C-2b),
2.57 ppm (ddd, J=9.7, 4.9, 3.4 Hz, 1H; C-6); 13C NMR (101 MHz,
D2O): d=74.4 (C-4), 67.6 (C-5), 67.5 (C-3), 62.4 (C-6), 59.6 (C-7),
48.9 ppm (C-2).
Methyl 2,6-dideoxy-2,6-imino-d-mannonate hydrochloride (3): 2-
Amino-6-bromo-2,6-dideoxy-d-mannono-1,4-lactone hydrochloride
(8, 0.60 g, 2.2 mmol), was co-evaporated thrice with dry toluene,
put under argon and suspended in dry MeOH (12 mL). The suspen-
sion was cooled to 0 8C before addition of distilled triethylamine
(1.2 mL, 8.7 mmol), and the resulting clear solution was stirred
overnight. The reaction mixture was concentrated under reduced
pressure before being taken up in acetonitrile (15 mL) and charged
with 1,1,1,3,3,3-hexamethyldisilazane (2.5 mL, 12 mmol) and copper
sulfate pentahydrate (cat.). After 1 h, the reaction mixture was con-
centrated and a fraction of 234 mg (0.57 mmol) was purified by
column chromatography (1–2.5% 1,4-dioxane/CH2Cl2) to give the
per-TMSylated compound (162 mg, 0.40 mmol). The protected
product was put under argon and dissolved in MeOH (8 mL), and
acetyl chloride (1 equiv) was added to generate HCl in situ. The
mixture was stirred for 0.5 h, after which the compound was con-
centrated and co-evaporated with MeOH to yield the title com-
pound (98 mg, 0.40 mmol, 70% over two steps). [a]20D : +31.8 (c=1,
MeOH); 1H NMR (400 MHz, D2O): d=4.40 (dd, J=5.3, 4.8 Hz, 1H; C-
5), 4.17 (ddd, J=9.5, 4.1, 2.8 Hz, 1H; C-3), 4.09 (d, J=4.4 Hz, 1H; C-
6), 3.86 (dd, J=5.6, 2.7 Hz, 1H; C-4), 3.82 (s, 3H; OCH3), 3.44 (dd,
J=12.2, 9.6 Hz, 1H; C-2a), 3.13 ppm (dd, J=12.2, 4.2 Hz, 1H; C-2b);
13C NMR (101 MHz, D2O): d=168.1 (C-7), 71.1 (C-4), 69.9 (C-5), 64.2
(C-3), 58.8 (C-6), 53.4 (OCH3), 43.5 ppm (C-2).
Sodium 2,6-dideoxy-2,6-imino-d-mannonate (4): Methyl 2,6-di-
deoxy-2,6-imino-d-mannonate hydrochloride (3, 24 mg, 0.10 mmol)
was dissolved in H2O (0.5 mL). A sodium hydroxide solution (1m
aq., 170 mL, 0.17 mmol) was added, and the mixture was stirred for
2 h. The mixture was concentrated under reduced pressure to yield
the title compound, pure but with added sodium hydroxide. [a]20D :
@7.2 (c=1, MeOH); 1H NMR (400 MHz, D2O): d=4.01 (m, 1H; C-3),
3.71 (t, J=9.7 Hz, 1H; C-5), 3.60 (dd, J=9.6, 3.2 Hz, 1H; C-4), 3.01
(dd, J=14.6, 2.7 Hz, 1H; C-2a), 2.95 (d, J=9.8 Hz, 1H; C-6),
2.75 ppm (dd, J=14.6, 1.6 Hz, 1H; C-2b); 13C NMR (101 MHz, D2O):
d=178.4 (C-7), 74.1 (C-4), 70.6 (C-5), 69.1 (C-3), 65.2 (C-6), 47.9 ppm
(C-2).
2,6-Dideoxy-2,6-imino-d-mannonic amide (5): 2-Amino-6-bromo-
2,6-dideoxy-d-mannono-1,4-lactone hydrochloride (8, 500 mg,
1.8 mmol), was co-evaporated thrice with dry toluene, put under
argon and suspended in dry MeOH (10 mL). The suspension was
cooled to 0 8C before addition of distilled triethylamine (1.0 mL,
7.2 mmol), and the resulting clear solution was stirred overnight.
The reaction mixture was concentrated under reduced pressure,
yielding the methyl ester as a white semicrystalline solid. The resi-
due was dissolved in ammonia in MeOH (6m, 10 mL, 60 mmol) and
stirred overnight. The reaction mixture was concentrated under re-
duced pressure, affording 2,6-dideoxy-2,6-imino-d-mannonic amide
(5) in quantitative yield. An analytical sample was prepared by crys-
tallisation from pure MeOH (133 mg, 0.76 mmol, 42%). [a]20D =
@31.68 (c=0.5, H2O); 1H NMR (399 MHz, D2O): d=3.97 (m, 1H; C-
3), 3.70 (t, J=9.7 Hz, 1H; C-5), 3.57 (dd, J=9.6, 3.1 Hz, 1H; C-4),
3.07 (d, J=9.8 Hz, 1H; C-6), 2.99 (dd, J=14.6, 2.7 Hz, 1H; C-2a),
2.75 ppm (dd, J=14.6, 1.6 Hz, 1H; C-2b); 13C NMR (101 MHz,
DMSO): d=173.5 (C-7), 74.9 (C-4), 70.0 (C-5), 68.7 (C-3), 63.3 (C-6),
49.1 ppm (C-2); HRMS: m/z calcd for C6H12O4N2 : 177.08698 [M+H]
+;
found: 177.08683.
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